abstract |
Compounds characterized generally as imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I n n n wherein A is selected from CO and SO 2 ; wherein X is selected from oxygen atom and methylene; wherein B is selected from imidazolyl and benzimidazolyl groups; wherein R 1 is selected from hydrido, methyl, ethyl, isopropyl and n-propyl; wherein R 2 is phenylmethyl; wherein each of R 3 and R 5 is hydrido; wherein R 4 is selected from n n n wherein V is selected from hydrido and methyl; wherein R 6 is cyclohexylmethyl; wherein R 7 is selected from isobutyl, cyclopropyl and cyclopropylmethyl; wherein q is a number selected from zero through three, inclusive; and wherein n is a number selected from zero through three, inclusive; or a pharmaceutically-acceptable salt thereof. |